Chemistry beyond the molecule by Desiraju, Gautam R.
For a long time chemists tried to under-stand nature at a level that was purelymolecular — they considered only
structures and functions involving strong
covalent bonds. But some of the most impor-
tant biological phenomena do not involve
making and breaking covalent bonds — the
linkages that connect atoms to form molec-
ules. Instead, biological structures are usual-
ly made from loose aggregates that are held
together by weak, non-covalent interactions.
Because of their dynamic nature, these inter-
actions are responsible for most of the
processes occurring in living systems.
Chemists have been slow to recognize the
enormous variety — in terms of structure,
properties and functions — offered by this
more relaxed approach to making chemical
compounds.
The slow shift towards this new approach
began in 1894, when Emil Fischer proposed
that an enzyme interacts with its substrate as
a key does with its lock1. This elegant mecha-
nism contains the two main tenets of what
would become a new subject, supra-
molecular chemistry2,3. These two principles
are molecular recognition and supramolecu-
lar function. 
Molecular recognition is implicit in the
lock-and-key model — provided both the
geometry and the non-covalent interactions
are compatible between the interacting part-
ners, you get recognition. Such highly specific
interactions also lead to useful supramolecu-
lar functions. For example, it is important
that an enzyme works only on the appropri-
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Supramolecular chemistry has grown in importance because it goes beyond
the molecule — the focus of classical chemistry. It also offers a fresh
interface with biological and materials science.
ate substrate. A key without its own lock or a
lock without its own key is quite useless. 
The initial motivation behind supra-
molecular chemistry was to design chemical
systems that mimic biological processes.
The rise of the supramolecular approach
was aided by observations of stable com-
pounds that did not involve covalent
bonds. Early examples of these ‘addition
products’ include donor–acceptor complex-
es and clathrate compounds (Fig. 1). Some
donor–acceptor complexes do not involve
normal covalent bonding. Instead, they are
held together by one molecule donating elec-
trons, or perhaps sharing a hydrogen atom,
with another.
A classic example of a donor–acceptor
complex is formed by silver ions (Ag+) and
ethene (CH2=CH2), in which the ethene
donates some electrons from its double bond
to Ag+ (Fig. 1a). The interaction is not so
strong that it leads to a covalent bond, but it is
strong enough to form a stable complex. 
Back in 1948, H. M. Powell4 described a
series of what he called clathrates — derived
from the Latin clathratus, meaning ‘enclosed
by the bars of a grating’. These inclusion
compounds are formed when small molec-
ules, such as methanol, hydrogen sulphide or
sulphur dioxide, are completely enclosed in
cavities formed by a host compound, such as
the -quinol network (Fig. 1b).Here we have
addition products with little or no direct
attachment — and no covalent bonds —
between the ‘host’ and the ‘guest’. Powell’s
work was the beginning of what would
eventually become a major part of
supramolecular chemistry — the design of
host cages that allow the selective inclusion
and expulsion of guest molecules. One of
the oldest uses of clathrates is in crude oil
refining, in which undesirable paraffins are
removed from gasoline by trapping in
clathrate lattices.
The early clathrates were discovered by
chance, but rational design has led to
enhanced properties. For example, a host
matrix made from a copper-based polymer
material absorbs and releases methane. This
organic–inorganic hybrid competes with
porous zeolites in its absorptive capacity, and
could offer new applications for clathrates,
such as the purification of drugs and trap-
ping and storage of toxic materials5. 
Chemists could not understand these
inclusion compounds in terms of normal
covalent bonding, and they were often rele-
gated to the fringes of chemistry. But with the
discovery of useful properties, chemists had
to take these compounds seriously — the
citadel of the isolated molecule was vulnera-
ble after all.
Intermolecular interactions
The term supramolecular chemistry was
coined in 1969 by Jean-Marie Lehn in his
study of inclusion compounds and
cryptands (Fig. 1c)2. The award of the 1987
Nobel Prize in Chemistry to Charles
Pedersen, Donald Cram and Lehn signified
the formal arrival of the subject on the chem-
ical scene. Lehn defined supramolecular
Figure 1 Supramolecular structures formed by intermolecular interactions. a, A donor–acceptor complex involving silver and ethene. b, Hydroquinone
molecules assemble into a clathrate using hydrogen bonds. This means they can form solid-state host–guest complexes in which the hydroquinone
network is the host and the guest is a small molecule, such as the xenon atom shown. c, A cryptand contains a spherical internal cavity studded with
donor sites, suitable for enclosing a metal ion. Ultraviolet light absorbed by the cryptand shown here excites the metal ion, Eu(III), which then emits
radiation at longer (visible) wavelengths.
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chemistry as “the chemistry of the inter-
molecular bond”. Just as molecules are built
by connecting atoms with covalent bonds,
supramolecular compounds are built by
linking molecules with intermolecular inter-
actions. 
Supramolecular structures are the result
of not only additive but also cooperative
interactions, and their properties generally
follow from their supramolecular character
(Boxes 1, 2). So even with the clathrates, their
whole is more than the sum of their parts.
These properties are important in both
materials science (magnetism, conductivity,
sensors, nonlinear optics) and biology
(receptor–protein binding, drug design,
protein folding).
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In any supramolecular assembly, a large
number of intermolecular interactions is
possible — but only a few are actually
observed. The weakness of these interactions
makes it difficult to predict supramolecular
structures and means that, in solution,
supramolecular structures are not always
stable over time. But this flexibility also
means that they are frequently favoured in
important mechanisms, notably in biologi-
cal reactions and in crystallization processes,
where the ability to form short-lived transi-
tion states and to perform trial-and-error
correction easily is essential.
Intermolecular interactions are divided
into two classes: isotropic, medium-range
forces and anisotropic, long-range forces.
Isotropic forces define the shape of the indi-
vidual molecules, as well as size and close
packing of molecules, whereas anisotropic
forces determine intermolecular orienta-
tions and functions. For example, the three-
dimensional shapes of biomolecules, such
as proteins and enzymes, are the result 
of medium-range intermolecular inter-
actions. At a simple level, all molecular
recognition can be said to arise from
isotropic interactions, in other words by the
fitting together of bumps and hollows
among the components of the supramolec-
ular structure. But most directional effects
— and function is related to these effects —
depend on the anisotropic interactions.
Generally, the anisotropic interactions
Box 1Hard applications
Supramolecular chemistry has always
been associated with new materials
and applications. Chemistry is driven
by the desire for new functions, with
the study of structure as a necessary
first step towards the achievement of
that goal. Ideally, useful materials
would be designed by taking a single
molecule and ‘sticking it’ to others of
its kind to form three-dimensional
assemblies. Implied in such a strategy
is the ability to fine-tune function
without necessarily disturbing
structure. Accordingly, the total
synthesis of a useful material can be
dissected into molecular and
supramolecular components.
Traditional organic chemistry already
provides all the necessary technology
for the synthesis of the molecular
building blocks. Supramolecular
synthesis, which requires
manipulation of intermolecular
interactions, is still evolving.
Most solid-state devices, such as
electronics, require a degree of order
that is only possible with crystalline
materials. Unlike porous materials,
crystals have densely packed
molecules and any chemical change
is likely to destroy the crystal and its
properties. But organoplatinum
molecules have successfully been
engineered to make a crystalline
material that reversibly binds sulphur
dioxide (SO2) gas
18. When the
colourless organoplatinum crystals
are bathed in SO2 they turn bright
orange and their total volume
increases by about a quarter, but the
crystals remain perfectly ordered.
The SO2 can be absorbed and
expelled many times without loss of
crystallinity. Part of the reason for this
remarkable behaviour is that the
crystalline framework is held together
by supramolecular interactions — a
string of hydrogen bonds — which
can more easily tolerate such
deformation. These organoplatinum
crystals might find use as a gas-
storage device, a sensor or even as
an optical switch.
Nanocrystalline materials with
ultrafine grains are potentially useful
in molecular-scale electronics as
magnetic19, semiconducting,
dielectric and ferroelectric materials.
Part of the problem chemists have
with molecule-based systems is
connecting them to the macroscopic
world. One approach is to modify a
nanocrystalline surface with
supramolecular components. For
example, a ruthenium complex bound
to nanocrystalline titanium dioxide
gives a supramolecular structure that
undergoes photochemically driven
electron- and energy-transfer
processes. This makes them
attractive materials for use in solar
cells20. Supramolecular aggregates of
organic molecules have also been
used to make molecular switches,
whose conductivity is controlled by
the chemical state of the molecule.
Chemical sensors based on such
switches could in theory be used to
detect individual molecules of a
pollutant. G.R.D.
Figure 2 The building blocks of supramolecular chemistry. The structural features of supramolecular
assemblies are best described in terms of supramolecular synthons — spatial arrangements of
molecules involving specific intermolecular interactions. a, The hydrogen-bonded symmetrical pair
of carboxyl groups (CO2H) is perhaps one of the easiest identified of supramolecular synthons. The
two linear hydrogen bonds (dotted lines) provide a structural motif that is surprisingly durable and
can be used to build structures based on b, one-, c, two- and d, three-dimensional patterns. 
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involve partially charged atoms, such as
nitrogen, oxygen, chlorine, phosphorus
and sulphur.
Isotropic interactions include van der
Waals forces, which act between all atoms
and molecules. These can be repulsive or
attractive depending on the distance
between the interacting non-bonded
atoms, and are responsible for gross
supramolecular arrangements. Although
these forces are individually weak — they
have bond energies of 8 kJ mol1 compared
with the 400 kJ mol1 of covalent bonds —
they become significant when considered in
numbers. This is the essence of supramolec-
ular thinking. The remarkable ability of the
house lizard to stick to a ceiling is a result of
millions of van der Waals interactions
formed by the spatulae at the ends of fine
hairs that cover the soles of its feet6. 
Although at a simple level molecular
recognition can be said to hinge on isotropic
interactions, at a higher level it is an
anisotropic interaction that is the master
key: the hydrogen bond7. In any hydrogen
bond, X–H…A, a hydrogen atom acts as a
bridge between two atoms X and A. These
atoms always tend to be negatively charged
(electronegative), which gives the hydrogen
bond an electrostatic character, as the
electropositive hydrogen atom holds the
negative atoms in thrall.
If X and A are both quite electronegative,
for example in N–H…O, the hydrogen bond
is ‘strong’ or ‘conventional’ (20–40 kJ
mol1). But if either or both X and A are of
moderate to weak electronegativity, such as
in C–H…O, the hydrogen bond is ‘weak’ or
‘non-conventional’ (2–20 kJ mol1)8. In
some systems, such as those involving the
HF2
 ion, the strength of the hydrogen
bonds can reach quasi-covalent levels (170 kJ
mol1). Hydrogen bonds can also form
between more than two atoms. The impor-
tance of hydrogen bonds that are formed
with double and triple bonds, such as CC
and CC, is increasingly being recognized.
For example, hydrogen bonds formed by
groups such as OH, NH and CH with the
double bonds in aromatic rings are recog-
nized as being key in the stabilization of 
biomolecular structures9. 
In general, the hydrogen bond is a
composite interaction, which can have
pronounced covalent, electrostatic or van
der Waals components and consequently
spans a wide energy range. The strength of
interaction dictates the length and orienta-
tion of the hydrogen bond: short, linear
bonds are almost always the strongest. But
even weak bonds can be significant. Weak
interactions tend to be hydrophobic, so they
can persist in ionic solvents better than
stronger hydrogen bonds.
Predicting supramolecular structures is
hard, not only because of the sheer numbers
of possible interactions involved, but also
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because in energetic terms there is not much
to choose between these various interac-
tions. If one interaction is not much more
energetically favourable than the others,
then there is no clear winner to predict. The
challenge for the supramolecular chemist
attempting to synthesize these structures is
to ensure that the molecules involved are 
oriented in such a way that maximizes the
strength of the desired interactions. Two
examples of instances where intermolecular
interactions are crucial are crystal engineer-
ing and crystallization.
Crystal engineering
Organic crystals are supramolecular entities
in that they are built from molecules. In
crystal engineering, the supramolecular
chemist aims to design and control packing
arrangements to design crystals with specific
properties. But this is not routinely possible
from knowledge of the molecular structure
alone. The best chemists can do is to find
recurring packing patterns adopted by cer-
tain functional groups and rely on the
robustness of such motifs to create new
solid-state structures. These small repetitive
units are called supramolecular synthons10.
They economically but fully define the
essence of a structure, and embody specific
intermolecular interactions (Fig. 2). Repeti-
tion is what qualifies a structural motif to be
considered a synthon and it is repetition that
is the key to successful crystal engineering. 
Even after identifying an important inter-
molecular interaction, failure to predict a
crystal structure can arise because the same
interaction can be used to make many differ-
ent synthons. For example, the carboxyl
group (CO2H) usually assembles in crystals
via pairs of O–H…O hydrogen bonds11. But
in cubane acids, the carboxyls form a syn-
thon containing both O–H…O and
C–H…O interactions (Fig. 3, overleaf).
Crystal engineering is shifting its focus
from devising structures to designing prop-
erties. Property design can only follow from
structure and our understanding of the
principles by which molecules assemble into
crystals is still rudimentary. Chemists are
trying various computational and experi-
mental approaches towards crystal design.
And the synthon concept tries to simplify
what is essentially a very difficult problem.
But even with apparently straightforward
synthons, things can go wrong.
In coordination polymers, for example,
the relatively strong coordinate bonds (a
type of covalent bond) between organic 
molecules and metal atoms are used to 
generate a solid network. This approach
offers greater structural repetition because
the coordinate bonds have both strength and
explicit geometries. The first metal–organic
networks were developed to mimic zeolites
— microporous materials used for catalysis
and separation processes. But even these
seemingly reliable synthons failed when the
packing density was low — more often than
not the porous structure was unstable to
collapse. The latest generation of open net-
works, which use a dicarboxylate linker to
help stabilize the structure, can survive the
loss or exchange of guest molecules12.
Crystallization of molecules in solution is
also a supramolecular process. Like other
chemical reactions, it is governed by thermo-
dynamic and kinetic factors. In molecular
chemistry, pure energy considerations —
enthalpy — are usually the decisive factor, so
chemists only have to worry about identify-
ing the strongest and weakest bonds, because
they usually want to make the strongest
Box 2Soft solutions
On the softer, non-crystalline side of
supramolecular chemistry, desirable properties
include solubility and chirality (molecular
asymmetry). For example, a water-soluble
polyfullerene has been synthesized using
supramolecular methodology21. The reactants are
prearranged in the cavity of a cyclodextrin, a
container molecule, and then the polymerization is
carried out. Potential biomedical applications of
this supramolecular polymer follow from the fact
that it scavenges the natural ‘free radical’,
1,1-diphenyl-2-picrylhydrazyl, more strongly than
C60 itself, and that it cleaves DNA oligonucleotides
in the presence of light.
Hydrogen-bonded systems often display
chirality at the supramolecular level. Chemists
want to control chirality so that supramolecular
products are purely left- or right-handed isomers,
and not a mixture of both. Supramolecular
structures can now be designed to form sufficiently
stable hydrogen bonds that pure-handed isomeric
assemblies can be isolated22. The efficacy of drugs
that are administered in crystalline form as fine
powders can depend strongly on whether they
have the correct isomeric structure and also the
correct polymorphic structure.
Polymorphism is when a given molecule can
exist in different crystalline forms, which are stable
under different conditions. Polymorphs can
therefore be thought of as supramolecular isomers,
species in which the relative positioning of the
same molecules is different. Polymorphs of a drug
can have quite different properties. Their
solubilities can be different, as well as their
biological activity. In some cases, the less stable
form will crystallize first, and then slowly
transform, over time, into the more stable crystal.
This can be a problem if the active form of a drug
is the less stable polymorph, and turns into the
more stable — but less active and perhaps even
harmful — form during storage. In this context,
can one design a molecule that is guaranteed to
crystallize in a particular polymorphic form under
physiological conditions? This is now a
supramolecular challenge for the pharmaceutical
industry. G.R.D.
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bonds and break the weakest. But in
supramolecular chemistry, there are so many
possible interactions that you have to
consider both the enthalpy and entropy (dis-
order) inherent in every interaction. It is
surprising, then, that although putative
crystal structures can be similar in terms of
energy, many organic molecules yield only
one crystal structure under given conditions.
Molecules seem to know how to crystallize
into the correct structure, even if chemists
cannot predict it.
Crystallization is a complex but highly
efficient process in which a number of mol-
ecular groups compete with each other to be
sites for intermolecular interactions that
might lead to a stable crystal structure.
Before the earliest stage of crystallization —
known as nucleation — all molecular groups
present in the solution try out different
possible routes to alternative intermolecular
interactions. But only a few of these inter-
actions will be thermodynamically, kineti-
cally or statistically sustained. The stable
interactions lead to robust synthons and
alternative possibilities are quickly and effi-
ciently excluded. In this respect, there are
similarities between the crystallization of
a small organic molecule and the folding 
of a protein. Both proceed through inter-
mediate, structure-determining clusters,
resulting in a considerable increase in 
crystallization or folding efficiency. 
A fascinating example of such a mechan-
ism is provided by molybdenum chemistry.
Molybdenum can form giant molecular
clusters or rings with nanometre-sized
cavities. Addition of two Mo36 ‘hub-caps’ to
the wheel-like Mo176 cluster results in a Mo248
cluster13. The hub-caps are not stable in
solution, showing that crystallization can
proceed in steps, with complex structures
forming from more simple ones that are not
necessarily stable on their own. 
published on page 452 of this issue17. The
authors of this paper have created supra-
molecular nanotubes that have important
biological activity in vivo (Fig. 4). By syn-
thesizing cyclic peptides consisting of alter-
nating D- and L-amino acids, a synthon that
self-assembles into a nanotube is created.
The resulting nanotubes have selective
antibacterial activity in mice by increasing
the permeability of bacterial membranes.
They are highly effective against drug-
resistant bacteria, highlighting the advan-
tages of a non-biological treatments over
conventional ones.
Friedrich Wöhler’s synthesis of urea in
1828, the first laboratory synthesis of a natu-
rally occurring compound, symbolized the
end of the vitalistic approach to chemistry —
the idea that living organisms differ from
non-living substances because they possess a
‘vital force’. But with the arrival of Emil 
Fischer and supramolecular chemistry,
chemists are now more than ever concerned
with the transition from chemistry to biolo-
gy. How do life processes work? The fantastic
levels of specificity achieved by biological
machines may be reduced to weak interac-
tions, to chemical recognition and function,
and inexorably down to physics itself. Yet, a
reductionist approach is simplistic beyond
the extreme. A scientifically more acceptable
view of vitalism is that living and non-living
matter differ not in content but rather in
organizational complexity — and our
understanding of this theme may well turn
out to be the biggest breakthrough in
supramolecular science. 
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Similarly, solvation — roughly the oppo-
site to crystallization — is a phenomenon in
which the enthalpic advantage of retaining
solvent in a crystal outweighs the entropic
advantage of expelling it into the bulk sol-
vent14. An understanding of crystallization is
important for the development of supramole-
cular chemistry and crystal engineering; both
experimental and computational approaches
(molecular dynamics) are currently being
used to tackle this exciting problem.
A study of the protein apoferritin recently
provided the first ever observations of 
protein nucleation15. By using atomic force
microscopy, tiny clusters of apoferritin can
be watched as they slowly grow or dissolve.
Protein crystallization is more an art than a
science, yet it is vital for determining protein
structure.
A quiet revolution
Almost unobtrusively, chemistry is changing
from a subject to a language that is needed to
communicate core issues in biological and
materials science. This change will surely
lead to striking and unexpected practical
applications, and supramolecular chemistry
is at the vanguard (Boxes 1 and 2). Stephen
Lippard recently made a ‘wish list’ for chem-
istry that represents this change16. Beyond
what I have already discussed here, new
goals for supramolecular chemistry include
building porous structures — clathrates
or coordination compounds — that have
internal sites for catalysis, and designing
solid-state reactions that are environment-
ally friendly because they are solvent free. 
So far, the success stories include one
Figure 3 In many cubane acids, the carboxyl
groups (CO2H) form a synthon based on
extended O–H…O and C–H…O bonds. In
4-bromocubanecarboxylic acid, for example,
the C–H…O hydrogen bond provides the
overall synthon with additional support11. It is
thought that without this interaction, the
exotic topology could not be realized.
Figure 4 Supramolecular approach to a
biological problem. Cyclic peptides with
alternating D- and L-amino acids create a flat,
ring-shaped synthon. When several cyclic
peptides are stacked together they can self-
assemble into a stable nanotube. The walls of the
tube are -pleated sheets. In mice, these
nanotubes have selective antibacterial activity by
increasing the permeability of bacterial
membranes17. (The structure shown here
features different side groups from those used by
Fernandez-Lopez et al. in ref. 17.)
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